Bullish Moving Averages
0
Bearish Moving Averages
16
Back Stocks profile
Open Price
12.20Prev. Close
12.4500Volume
765057.00Value
9173033.43Market Cap
450.10
Price to Earnings
40.10
Price to Book Value
7.40
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
245.57
Net Profit TTM
11.21
Cash From Operating Activity
32.42
Return on Equity %
18.35
EMA & SMA
Bullish Moving Averages
0
Bearish Moving Averages
16
DELIVERY AND VOLUME
05 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
12.28
Second Resistance
12.57
Third Resistance
12.89
First Support
11.67
Second Support
11.35
Third Support
11.06
Relative Strength Index
45.54
Money Flow Index
49.3
MACD
-0.1
MACD Signal
-0.07
Average True Range
0.38
Average Directional Index
14.17
Rate of Change (21)
-5.59
Rate of Change (125)
-50.21
Commodity Channel Index
-59.4
Williams %R
-56.5
BETA
1 Month
-0.26
3 Month
0.17
1 Year
0.06
3 Year
PRICE CHANGE ANALYSIS
1 Week
Low
High
11.52
12.55
1 Month
Low
High
11.52
12.6
3 Months
Low
High
10
15
6 Months
Low
High
9.45
26.58
1 Year
Low
High
9.45
33.35
M. K. Proteins Ltd - 543919 - Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for transactions in Shares of the Company for all the Employees, Directors, Key Managerial Personnel, Promoters, designated persons and their immediate relatives or any other insider shall remain closed from Monday, 1st July, 2024 till end of 48 hours after the declaration of Un-Audited Financial Results of the Company for the First Quarter ended 30th June, 2024.M. K. Proteins Ltd - 543919 - Announcement under Regulation 30 (LODR)-Newspaper Publication
lPursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the copies of Newspaper advertisements published in the Financial Express (English Edition) and Jansatta (Hindi Edition) regarding the Audited Financial Results of the Company for the quarter and year ended March 31, 2024M. K. Proteins Ltd - 543919 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In compliance of Regulation 24A of SEBI (LODR) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, we are submitting herewith Annual Secretarial Compliance Report for the year ended 31st March 2024.M. K. Proteins Ltd - 543919 - Outcome Of The Board Meeting Held Today I.E. 29Th May, 2024
Pursuant to the Regulations 30 and 33 of SEBI (LODR) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, May 29, 2024.M. K. Proteins Ltd - 543919 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 29Th May, 2024
Pursuant to the Regulations 30 and 33 of SEBI (LODR) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, May 29, 2024, inter alia, considered and approved: 1. Audited Standalone Financial Results for the quarter and for the FY ended on 31st March, 2024 together with a statement of Cash Flow, Statement of Assets and Liabilities for the same period; 2. Auditors Report on the said Financial Results; 3. Declaration regarding unmodified opinion on Audited Standalone Financial Results under Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2016; 4. The appointment of K K Sinha & Associates, as Cost Auditors of the Company for the period 2024-25. 5. Related Party Transactions for the Half Year ended 31.03.2024. The meeting of the Board of Directors commenced at 03:00 p.m. and concluded at 4:30 p.m.M. K. Proteins Ltd - 543919 - Board Meeting Intimation for Consideration And Approval Of : 1. The Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2024 2. Any Other Items With The Permission Of The Chairman.
M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended 31st March, 2024; 2. Any other items with the permission of the chairman.M. K. Proteins Ltd - 543919 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyM. K. Proteins Ltd 2CIN NO.L15500HR2012PLC046239 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 19.82 4Highest Credit Rating during the previous FY A 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: NEHA AGGARWAL Designation: COMPANY SECRETARY EmailId: [email protected] Name of the Chief Financial Officer: VINOD KUMAR Designation: WTD AND CFO EmailId: [email protected] Date: 30/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.M. K. Proteins Ltd - 543919 - Disclosure Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015M. K. Proteins Ltd - 543919 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015, For The Period From 01St April 2023 To 31St March, 2024.
With reference to Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, please find enclosed the certificate dated April 10, 2024 received from M/s. RPS Khurana & Associates, Practicing Company Secretary certifying that the company has not received any request relating to the transfer of equity shares, sub-division, consolidation, renewal and split, during the period from 01st April 2023 to 31st March, 2024.M. K. Proteins Ltd - 543919 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, please find attached herewith copy of Certificate issued by M/s Big Share Services Private Limited bearing SEBI Registration No INR000001385, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended March 31, 2024.The latest market price of M K Proteins Ltd. on NSE was Rs. 11.99 as of today.
The opening share price of M K Proteins Ltd. was Rs. 12.20 as of today.
The 52-week high share price of M K Proteins Ltd. was Rs. 33.40.
The 52 week low share price of M K Proteins Ltd. was Rs. 9.40.
The PE ratio of M K Proteins Ltd. is 0.00. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest bonus issue declared by M K Proteins Ltd. was as of 2024-03-15. The bonus ratio declared in this issue was 2:1. Please refer to the Corporate Actions section for further details.
The latest split issue declared by M K Proteins Ltd. was as of 2023-11-10. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about M K Proteins Ltd..